HAG
GSK icon

HighPoint Advisor Group’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$556K Buy
14,478
+2,431
+20% +$93.4K 0.03% 351
2025
Q1
$469K Buy
12,047
+2,899
+32% +$113K 0.03% 371
2024
Q4
$330K Sell
9,148
-1
-0% -$36 0.02% 477
2024
Q3
$374K Sell
9,149
-1,210
-12% -$49.5K 0.02% 428
2024
Q2
$412K Buy
10,359
+704
+7% +$28K 0.02% 392
2024
Q1
$436K Sell
9,655
-1,162
-11% -$52.5K 0.03% 384
2023
Q4
$463K Buy
+10,817
New +$463K 0.03% 370
2022
Q2
$607K Buy
+14,084
New +$607K 0.07% 243
2021
Q3
$583K Sell
15,255
-221
-1% -$8.45K 0.06% 277
2021
Q2
$616K Buy
15,476
+1,547
+11% +$61.6K 0.06% 262
2021
Q1
$510K Sell
13,929
-631
-4% -$23.1K 0.06% 262
2020
Q4
$521K Sell
14,560
-349,569
-96% -$12.5M 0.06% 248
2020
Q3
$625K Sell
364,129
-2,384
-0.7% -$4.09K 0.11% 148
2020
Q2
$782K Sell
366,513
-6,228
-2% -$13.3K 0.17% 112
2020
Q1
$1.07M Buy
372,741
+7,778
+2% +$22.3K 0.25% 80
2019
Q4
$875K Sell
364,963
-334
-0.1% -$801 0.18% 100
2019
Q3
$807K Buy
365,297
+299,903
+459% +$663K 0.18% 106
2019
Q2
$650K Buy
65,394
+49,241
+305% +$489K 0.15% 116
2019
Q1
$639K Sell
16,153
-66
-0.4% -$2.61K 0.16% 132
2018
Q4
$669K Sell
16,219
-149
-0.9% -$6.15K 0.18% 129
2018
Q3
$663K Buy
16,368
+538
+3% +$21.8K 0.18% 135
2018
Q2
$646K Sell
15,830
-141
-0.9% -$5.75K 0.17% 147
2018
Q1
$655K Sell
15,971
-995
-6% -$40.8K 0.18% 145
2017
Q4
$620K Buy
16,966
+231
+1% +$8.44K 0.18% 141
2017
Q3
$602K Buy
16,735
+1,522
+10% +$54.8K 0.19% 144
2017
Q2
$617K Hold
15,213
0.2% 136
2017
Q1
$617K Buy
15,213
+1,760
+13% +$71.4K 0.2% 136
2016
Q4
$557K Sell
13,453
-1,413
-10% -$58.5K 0.18% 155
2016
Q3
$571K Sell
14,866
-401
-3% -$15.4K 0.2% 130
2016
Q2
$678K Buy
15,267
+3,721
+32% +$165K 0.24% 108
2016
Q1
$497K Sell
11,546
-2,299
-17% -$99K 0.3% 98
2015
Q4
$554K Sell
13,845
-1,221
-8% -$48.9K 0.36% 87
2015
Q3
$579K Sell
15,066
-520
-3% -$20K 0.64% 63
2015
Q2
$649K Buy
15,586
+1,400
+10% +$58.3K 1% 43
2015
Q1
$670K Buy
+14,186
New +$670K 1.02% 43